Glaxosmithkline Share News (GSK)

UPDATE 2-Sex video new twist in GSK China bribery scandal

(Adds detail from ChinaWhys report) By John Ruwitch, Adam Jourdan and Ben Hirschler SHANGHAI/LONDON, June 30 (Reuters) - GlaxoSmithKline Plc's tangled web of problems in China, including a sex video of its former China chief and anonymous emails alleging corruption, are highlighted i

MARKET COMMENT: FTSE 100 Posts Second Quarter Gain Despite Weak June

Glaxo submits new drug application for asthma treatment

GlaxoSmithKline (GSK) on Monday announced that in partnership with US-listed Theravance it has submitted a supplemental new drug application (sNDA) to the US Food and Drug Administration (FDA) for two different doses of an asthma treatment taken through its Ellipta dry powder inhaler. The filing o

UPDATE: Glaxo Has "Zero Tolerance" For Corruption After Sex Tape Reports

Glaxo And Theravance Submits Supplemental NDA For Breo Ellipta

UK MIDDAY BRIEFING: BAE Systems Deepens Saudi Partnership

UK WINNERS & LOSERS: Gowin New Energy Doubles As China Goes Green

TOP NEWS: UK Mortgage Approvals Drop For Fourth Straight Month

UK MORNING BRIEFING: Shares Rise Amid Rush Of Company Reporting

PRESS: Glaxo China Bribery Probe Sparked By Sex Tape - Sunday Times

Sex video is new twist in GSK China bribery scandal

LONDON, June 29 (Reuters) - GlaxoSmithKline on Sunday confirmed the existence an intimate video recording of its former China head Mark Reilly, which the Sunday Times reported kicked off a bribery investigation that has damaged the drugmaker's business in China. The Sunday Times said the re

Sunday newspaper round-up: Bank Rate, State pensions, Baghdad

Over the longer-term, say five to ten years, it would be reasonable to expect borrowing costs to rise back to their pre-recesssion levels, of about 5%, but "it's probably quite a long way down the road" outgoing Bank of England Deputy Charlie Bean told Sky News in an interview. That comes after Gove

GSK, Genmab leukemia drug fails to meet main trial goal

June 27 (Reuters) - GlaxoSmithKline Plc and Genmab A/S said on Friday their cancer drug Arzerra failed to treat a type of leukemia more effectively than other drugs in a late-stage trial. Arzerra, known chemically as ofatumumab, was being tested in patients with a type of blood cancer known

GSK receives good news on ViiV's Trimeq HIV treatment

GlaxoSmithKline (GSK) shares moved higher on Friday after ViiV Healthcare, the HIV-focused business jointly owned with Pfizer, took a step forward in the marketing authorisation process for its Triumeq treatment. Based on two studies, the Committee for Medicinal Products for Human Use of the Europe

Glaxo: Viiv Healthcare's HIV Combined Treatment Step Closer To EU Approval